FGF7 and acute graft versus host disease: Along these lines, prophylactic treatment with recombinant keratinocyte growth factor protected mice from the development of lethal acute GVHD, presumably via reduction of intestinal epithelial apoptosis and diminished LPS-mediated pro-inflammatory cytokine release (25).